Online Yoga vs Acceptance and Commitment Therapy for Treating Chronic Musculoskeletal Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPalo Alto Veterans Institute for Research
About this trial
This study will compare online yoga with Acceptance and Commitment Therapy (ACT), an established treatment for chronic pain. We will compare the efficacy of the two treatments for reducing chronic musculoskeletal pain in veterans.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Veteran of the United States Armed Forces ≥ 18 years old
Chronic pain > 6 months related to at least one musculoskeletal pain-related diagnosis indicated by an ICD-9 or -10 code
Minimum pain intensity at screening ≥4 on a 0-10 using the Defense and Veterans Pain Rating Scale (DVPRS)
Not begun new pain treatments or medications in the past month
Disqualifiers
Participation in another clinical trial, unless given prior authorization from both our research team and that of the other study
Back surgery within the last 12 months
Back pain potentially attributed to a specific known condition
Baseline pain <4 or ≥9 on a 0-10 Numeric Rating Scale
Trial design
Design model
Parallel
Treatments tested in this trial
Yoga
BehavioralA 12-week online yoga course designed to treat pain.
Acceptance and Commitment Therapy (ACT)
BehavioralA 12-week behavioral therapy course designed to treat pain.
Treatment groups
274 Participants
are divided into 2 treatment groupsGroup A: Online YogaExperimental treatment 1 intervention
Group B: Acceptance and Commitment TherapyActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Pain Interference (Brief Pain Inventory-Short Form)
The degree to which pain impacts mood, walking and other daily activities, as measured by the Pain Interference Scale of the Brief Pain Inventory - Short Form (BPI-SF). The BPI-SF assesses intensity and impact of pain on functioning on a 0-10 rating scale, with higher scores indicating greater degree of interference.
Time frame
Baseline, End-of-treatment at 12 weeks, and 6 months after treatmentSecondary outcomes
1
Depression (BDI-II)
Symptoms of depression as measured by the Beck Depression Inventory (BDI-II). The BDI-II is comprised of 21 self-report questions, scored on a 0-3 scale, with higher scores indicating more depressive symptoms.
Time frame
Baseline, End-of-treatment at 12 weeks, and 6 months after treatment2
Sleep (Pittsburgh Sleep Quality Index)
Sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI). The PSQI is a a self-rated questionnaire that assesses sleep quality and disturbances over a 1-month interval.
Time frame
Baseline, End-of-treatment at 12 weeks, and 6 months after treatmentSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov